evolvedMD secures $34 million in Series B funding led by Goldman Sachs Alternatives to expand its integrated behavioral health services in primary care settings.
Information on the Target
evolvedMD, founded in 2017, is a leader in Collaborative Care Management (CoCM), providing integrated behavioral health services within primary care settings. The company employs a unique model that embeds behavioral health providers at more than 200 locations across Arizona, Utah, Florida, New Mexico, and Colorado. These on-site professionals are supported by clinical managers, care coordinators, and psychiatric nurse practitioners, ensuring high-quality mental health services in a convenient and trustworthy environment. evolvedMD has gained significant traction in increasing awareness and adoption of the CoCM model, particularly highlighted by a recent Milliman/Meadows study showcasing high adoption rates in Arizona, their home market.
Industry Overview in the Target’s Specific Country
The behavioral health industry in the United States has faced increasing demand as awareness of mental health issues rises. With mental health challenges affecting millions, there is a pressing need for accessible and effective care solutions. According to analysis by the National Institute of Mental Health, nearly one in five adults in the U.S. live with a mental illness, underscoring the necessity for integrated care models that streamline access to treatment.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
With the onset of innovative healthcare models like Collaborative Care, there is a shift towards integrating mental health services into primary care. This integration not only facilitates better patient ou
Similar Deals
ARCH Venture Partners, GV (Google Ventures) → Pelage Pharmaceuticals
2025
EQT Life Sciences, Sanofi Ventures → SpliceBio
2025
Blue Owl Capital → Latigo Biotherapeutics
2025
ABS Capital Partners → Greenspace Health
2025
Goldman Sachs Alternatives
invested in
evolvedMD
in 2025
in a Series B deal
Disclosed details
Transaction Size: $34M